 |
|
|
| |
Direct-acting Antivirals for Hepatitis C Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence After Locoregional Therapy or Liver Transplant Waitlist Dropout
|
| |
| |
Reported by Jules Levin
EASL 2017 April 19-23 Amsterdam Netherlands
Annsa C. Huang MD1, Neil Mehta MD2, Jennifer L. Dodge MPH3, Francis Y. Yao MD1,3, Norah A. Terrault MD2,3 1Department of Medicine, University of California, San Francisco 2Department of Medicine, Division of Gastroenterology, University of California, San Francisco 3Department of Surgery, Division of Transplant Surgery, University of California, San Francisco
|
| |
|
|
|
|
|
